Skip to content

A clinical trial to assess the efficacy of Ayurveda treatment in Jaanu Sandhigatavata (Primary Knee Osteoarthritis)

A randomized controlled trial to evaluate the efficacy of multimodal Ayurveda interventions in Jaanu Sandhigatavata (Primary Knee Osteoarthritis)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042792
Enrollment
150
Registered
2022-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

Central Council for Research in Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 40 to 70 years having diagnosed Knee osteoarthritis (OA) as per the ACR criteria with the following parameters will be included in the study: 1.Pain score of at least 2 (Numeric Pain rating scale) in most days of the last month; 2.American College of Rheumatology (ACR) functional status criteria class I, II and III 3.Serum vitamin D level of >30 ng/ml 4.Able and willing to give informed consent ACR criteria Pain in knee + Any 3 of the following: Age > 50 years Less than 30 minutes of stiffness Crepitus Bony tenderness Bony enlargement No palpable warmth

Exclusion criteria

Exclusion criteria: Patients with the following criteria will be excluded from the study: 1.Grade 4 and above radiographic changes in the affected knee (Kellgren-Lawrence classification) 2.Significant trauma to the knee including arthroscopy within preceding one year 3.History of knee joint replacement 4.BMI>=32 kg/m² 5.History of prior intra-articular corticosteroid or hyaluronic acidadministration within one month of the study 6.On corticosteroids 7.Rheumatoid arthritis, Psoriatic arthritis, Lupus 8.Uncontrolled HTN ( >160/100 mm Hg) 9.Uncontrolled DM (HbA1c >8.0) 10.Cardiac, hepatic or renal function impairment 11.History or active malignancy 12.Tendency for occurrence of recurrent renal calculi 13.Hypersensitivity to trial drugs 14.History or active substance abuse/ alcoholism 15.Any contraindication for MRI scan 16.Any other condition that in the opinion of the investigator may compromise the participantâ??s safety or compliance, interfere with evaluation or preclude completion of the study

Design outcomes

Primary

MeasureTime frame
Change in knee pain and functional disability from baseline assessed through WOMAC index scoreTimepoint: At baseline,30th day, 60th day, 90th day, 120th day, 150th day and 180th day.

Secondary

MeasureTime frame
1.Change in score for pain, stiffness and physical function of WOMAC from baseline 2.Change in the range of motion of knee joint (assessed through goniometer) 3.Change in the score of Numeric Pain rating scale from baseline 4.Change in Pain Disability Index score from baseline 5.Change in health related quality of life from baseline assessed through SF-12 questionnaire 6.Change in inflammatory biomarkers (highly sensitive C-reactive protein, IL-6) 7.Change in the need of Rescue Analgesic medication 8.Change in knee structural changes assessed through MRI 9.Change in Bone mineral density assessed through DEXA scan 10.Incidence of AE/ADRTimepoint: At baseline,30th day, 60th day, 90th day, 120th day, 150th day and 180th day.

Countries

India

Contacts

Public ContactDr Kishor Patel

Central Ayurveda Research Institute, New Delhi

kishoreworld007@gmail.com7405403106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026